Schizophrenia as a disorder of molecular pathways

Szatmár Horváth, K. Mirnics

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Over the last decade, transcriptome studies of postmortem tissue from subjects with schizophrenia revealed that synaptic, mitochondrial, immune system, gamma-aminobutyric acidergic, and oligodendrocytic changes are all integral parts of the disease process. The combined genetic and transcriptomic studies argue that the molecular underpinnings of the disease are even more varied than the symptomatic diversity of schizophrenia. Ultimately, to decipher the pathophysiology of human disorders in general, we will need to understand the function of hundreds of genes and regulatory elements in our genome and the consequences of their overexpression and reduced expression in a developmental context. Furthermore, integration of knowledge from various data sources remains a monumental challenge that has to be systematically addressed in the upcoming decades. In the end, our success in interpreting the molecular changes in schizophrenia will depend on our ability to understand the biology using innovative ideas and cannot depend on the hope of developing novel, more powerful technologies.

Original languageEnglish
Pages (from-to)22-28
Number of pages7
JournalBiological Psychiatry
Volume77
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Schizophrenia
Aptitude
Information Storage and Retrieval
Regulator Genes
Transcriptome
Immune System
Genome
Technology

Keywords

  • Convergence
  • Gene Expression
  • Gene Network
  • Genetics
  • Postmortem
  • Schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Schizophrenia as a disorder of molecular pathways. / Horváth, Szatmár; Mirnics, K.

In: Biological Psychiatry, Vol. 77, No. 1, 01.01.2015, p. 22-28.

Research output: Contribution to journalArticle

Horváth, Szatmár ; Mirnics, K. / Schizophrenia as a disorder of molecular pathways. In: Biological Psychiatry. 2015 ; Vol. 77, No. 1. pp. 22-28.
@article{d21f80145fe24c5ab8eb96df337654bc,
title = "Schizophrenia as a disorder of molecular pathways",
abstract = "Over the last decade, transcriptome studies of postmortem tissue from subjects with schizophrenia revealed that synaptic, mitochondrial, immune system, gamma-aminobutyric acidergic, and oligodendrocytic changes are all integral parts of the disease process. The combined genetic and transcriptomic studies argue that the molecular underpinnings of the disease are even more varied than the symptomatic diversity of schizophrenia. Ultimately, to decipher the pathophysiology of human disorders in general, we will need to understand the function of hundreds of genes and regulatory elements in our genome and the consequences of their overexpression and reduced expression in a developmental context. Furthermore, integration of knowledge from various data sources remains a monumental challenge that has to be systematically addressed in the upcoming decades. In the end, our success in interpreting the molecular changes in schizophrenia will depend on our ability to understand the biology using innovative ideas and cannot depend on the hope of developing novel, more powerful technologies.",
keywords = "Convergence, Gene Expression, Gene Network, Genetics, Postmortem, Schizophrenia",
author = "Szatm{\'a}r Horv{\'a}th and K. Mirnics",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.biopsych.2014.01.001",
language = "English",
volume = "77",
pages = "22--28",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Schizophrenia as a disorder of molecular pathways

AU - Horváth, Szatmár

AU - Mirnics, K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Over the last decade, transcriptome studies of postmortem tissue from subjects with schizophrenia revealed that synaptic, mitochondrial, immune system, gamma-aminobutyric acidergic, and oligodendrocytic changes are all integral parts of the disease process. The combined genetic and transcriptomic studies argue that the molecular underpinnings of the disease are even more varied than the symptomatic diversity of schizophrenia. Ultimately, to decipher the pathophysiology of human disorders in general, we will need to understand the function of hundreds of genes and regulatory elements in our genome and the consequences of their overexpression and reduced expression in a developmental context. Furthermore, integration of knowledge from various data sources remains a monumental challenge that has to be systematically addressed in the upcoming decades. In the end, our success in interpreting the molecular changes in schizophrenia will depend on our ability to understand the biology using innovative ideas and cannot depend on the hope of developing novel, more powerful technologies.

AB - Over the last decade, transcriptome studies of postmortem tissue from subjects with schizophrenia revealed that synaptic, mitochondrial, immune system, gamma-aminobutyric acidergic, and oligodendrocytic changes are all integral parts of the disease process. The combined genetic and transcriptomic studies argue that the molecular underpinnings of the disease are even more varied than the symptomatic diversity of schizophrenia. Ultimately, to decipher the pathophysiology of human disorders in general, we will need to understand the function of hundreds of genes and regulatory elements in our genome and the consequences of their overexpression and reduced expression in a developmental context. Furthermore, integration of knowledge from various data sources remains a monumental challenge that has to be systematically addressed in the upcoming decades. In the end, our success in interpreting the molecular changes in schizophrenia will depend on our ability to understand the biology using innovative ideas and cannot depend on the hope of developing novel, more powerful technologies.

KW - Convergence

KW - Gene Expression

KW - Gene Network

KW - Genetics

KW - Postmortem

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84920662212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920662212&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2014.01.001

DO - 10.1016/j.biopsych.2014.01.001

M3 - Article

C2 - 24507510

AN - SCOPUS:84920662212

VL - 77

SP - 22

EP - 28

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 1

ER -